ClexBio

ClexBio is a biotechnology company that creates breakthrough solutions for tissue engineering and single-cell technology by combining advanced microfluidic technology with its proprietary hydrogel technology, CLEX. The CLEX technology allows for the formation of hydrogels with precise control and superior biocompatibility. This enables ClexBio to use microfluidic devices to form hydrogel microstructures containing delicate biological cargoes, such as living cells. ClexBio will develop an entirely new patient-specific bioengineered vascular graft to meet significant unmet clinical needs.